Director of Strategic Partnerships, myTomorrows
+ Bonus + Equity
Helping patients discover and access treatments
Job no longer available
Helping patients discover and access treatments
101-200 employees
Job no longer available
+ Bonus + Equity
101-200 employees
Company mission
To enable earlier and better access to all possible treatment options.
Role
Who you are
- You have an extensive network within healthcare and a proven track record in securing and managing high-value partnerships
- You are result-oriented, and want to drive innovation in healthcare
- You are passionate about driving meaningful partnerships within the pharmaceutical and healthcare industries
- You thrive in an entrepreneurial, dynamic and fast-paced environment
- You are excited about the prospect of frequent global travel and building relationships across different cultures on a global scale
- You have a strategic mindset with a focus on long-term goals and outcomes enabling the nurturing of long-term relationships
- You are a proactive problem solver who enjoys overcoming challenges and finding innovative solutions and are able to bring people together internally and externally
What the job involves
- As the Director of Industry Partnerships, you will play a pivotal role in driving physician, patient and revenue growth through strategic alliances with key industry stakeholders
- These partnerships will span from demand(e.g. patient advocacy groups, hospitals, sequencing companies), as well as supply (e.g. trial sites, clinical trial software providers)
- Develop and execute forward-thinking partnership strategies that propel myTomorrows’ mission and drive business growth
- Foster, develop, and maintain strong relationships with key stakeholders within the healthcare ecosystem, particularly in clinical trial recruitment
- Rapidly identify and capitalize on new opportunities to expand our partnership portfolio
- Collaborate with internal teams to ensure seamless integration and execution of partnership initiatives
- Represent the company at industry conferences, meetings, and events to build brand awareness, network with potential partners, and close deals
- Travel to clients, conferences, and prospects across the globe (40% of the time)
Our take
In Europe alone there are around 1 million patients with debilitating diseases who have few or no treatment options for their conditions. For many, experimental drugs may hold the key to effective treatment, but an alarming 95% of such patients will not meet the eligibility criteria to enter clinical trials for these potentially life-improving medications. For patients who cannot wait for new drugs to become fully approved and available, it has historically been very difficult to access treatments in development.
This is what myTomorrows has set out to change. Founded in 2012, myTomorrows is a platform that helps patients and physicians discover and access treatments in development. It charges pharmaceutical companies for its services in assisting with clinical trials, but for patients and physicians its services are free. With a model based on encouraging reciprocity, myTomorrows is looking to disrupt this market in a holistic way - changing things for the better and benefitting all sides.
With over 5000 patients helped, 500+ physician partners onboard, and access to over 300,000 clinical research studies, myTomorrows has managed to generate some impressive early metrics. This has attracted big investor interest, and myTomorrows is planning on using new funding to invest in new technology and increase its headcount.
In terms of market trends, the 'right to try' debate is still fierce across the world, but the shift in the last 20 years has clearly been towards liberalisation, especially in the US. It looks, then, like myTomorrows' prospects are going to get even stronger in the coming years.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
23% employee growth in 12 months
Company
Funding (last 2 of 5 rounds)
Nov 2025
$29m
LATE VC
Jan 2017
$11.7m
SERIES A
Total funding: $52m
Company benefits
- International work environment, scale-up energy, and flat organization
- Great career development opportunities in a growing company
- Learning and development budget, alongside internal knowledge-sharing sessions
- Attractive pension plan, full premium covered by us
- Hybrid work model
- Policies to support working parents
- Healthy lunch at the office
- Unlimited access to professional guidance by certified psychologists via OpenUp
- We celebrate freedom every year with an added holiday for Liberation Day on the 5th of May
Company HQ
Hoofddorppleinbuurt, Amsterdam, NH
Leadership
Ronald Brus
(Founder & CEO)A physician by trade, Ronald is also the co-founder and CBO of Leyden Labs, and spent over 14 years at biotech company Crucell.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job